Chronic everolimus treatment of high‐fat diet mice leads to a reduction in obesity but impaired glucose tolerance
Abstract Everolimus, which inhibits mTOR kinase activity and is clinically used in graft rejection treatment, may have a two‐sided influence on metabolic syndrome; its role in obesity and hyperglycemic in animals and humans, however, has been explored insufficiently. This study further determined ho...
保存先:
主要な著者: | Geng‐Ruei Chang (著者), Po‐Hsun Hou (著者), Chao‐Min Wang (著者), Ching‐Feng Wu (著者), Huang‐Kai Su (著者), Huei‐Jyuan Liao (著者), To‐Pang Chen (著者) |
---|---|
フォーマット: | 図書 |
出版事項: |
Wiley,
2021-04-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice
著者:: Geng-Ruei Chang, 等
出版事項: (2021) -
Subclinical hypothyroidism and impaired glucose tolerance during pregnancy
著者:: Wen-Ling Lee, 等
出版事項: (2023) -
Study of Impaired Glucose Tolerance in Pulmonary Tuberculosis
著者:: Jain MK, 等
出版事項: (2006) -
Perceived Symptoms in People Living with Impaired Glucose Tolerance
著者:: Susanne Andersson, 等
出版事項: (2011) -
Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
著者:: Nihar Ranjan Mohanty, 等
出版事項: (2022)